Dr. Sanber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
CRB1, room 16
Houston, TX 77030
Summary
- Based in Houston, Khaled Sanber, MD specializes in oncology, with a subspecialty in head and neck cancer. His educational background includes a fellowship in Medical Oncology at Johns Hopkins University, a residency in Internal Medicine at Baylor College of Medicine, a Ph.D. from University College London, and a medical degree from the University of Jordan Faculty of Medicine. Dr. Sanber is currently employed as an Assistant Professor at UT MD Anderson Cancer Center and has expertise in gene therapy, tumor immunotherapy, and medical oncology. He has numerous publications in prestigious journals and has received multiple awards for his research and academic excellence.
Education & Training
- Johns Hopkins UniversityFellowship, Medical Oncology, 2020 - 2023
- Baylor College of MedicineResidency, Internal Medicine, 2015 - 2020
- University College LondonPh.D., 2011 - 2014
- University of Jordan Faculty of MedicineClass of 2010
Certifications & Licensure
- TX State Medical License 2015 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Early Stage Professional Abstract Award International Society for Cell and Gene Therapy (ISCT), 2020
- Award for research presentation. Top 5 abstracts Baylor College of Medicine (BCM), Texas Children's Hospital (TCH), 2019
- Second place for quality improvement/patient safety poster category Texas Chapter of the American College of Physicians (TXACP), 2018
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsAutologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial.Meenakshi Hegde, Shoba Navai, Christopher DeRenzo, Sujith K Joseph, Khaled Sanber
Nature Cancer. 2024-06-01 - 61 citationsConstruction of stable packaging cell lines for clinical lentiviral vector productionKhaled S. Sanber, Sean Knight, Sam L. Stephen, Ranbir Bailey, David Escors
Scientific Reports. 2015-03-12 - 101 citationsCAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression.Kristen Fousek, Junji Watanabe, Sujith K. Joseph, Ann George, Xingyue An
Leukemia. 2021-01-01
Books/Book Chapters
Abstracts/Posters
- Predicting Risk of Clinical Deterioration: A Closer Look at Resident Handoffs and Rapid ResponseSanber K, Jacobson R, Tuthill S, Kaul B, Hemmige V, Guy E, Shah C, Greenberg S, ACP Associates Day; Society for General Internal Medicine (SGIM) Meeting, Houston, TX, 2018; Washington, DC, 2019, 1/1/2019
- Radiation priming improves the anti-tumor activity of HER2 CAR T cells in glioblastoma.Mullikin D, Joseph SK, Mathew P, Vita S, Byrd T, Sanber K, Krishnamurthy P, Lindsay H, Chakraborty R, Gaber MW, Ahmed N, Hegde M, American Society for Pediatric Hematology/Oncology (ASPHO) Conference, New Orleans, LA, 1/1/2019
- SHP2: sailing against tumor-mediated inhibition of chimeric antigen receptor T-cell therapySanber K, Nawas Z, Landi D, Lee C, Sengal A, Chakraborty R, Brunetti L, Sujith J, Mukherjee M, Ahmed N, Hegde M, Multiple presentations, Mutiple locations, 2017, 2018, 2019, 1/1/2019
- Join now to see all
Lectures
- SHP2: sailing against tumor-mediated inhibition of chimeric antigen receptor T-cell therapyHouston, TX - 1/1/2019
- Administration of HER2-CAR T cells after lymphodepletion safely improves T cell expansion and induces clinical responses in patients with advanced sarcomasAtlanta, GA - 1/1/2019
- Predicting Risk of Clinical Deterioration: A Closer Look at Resident Handoffs and Rapid ResponseHouston, TX - 1/1/2019
- Join now to see all
Grant Support
- Cancer Prevention and Research Institute of Texas (CPRIT) Training GrantCancer Prevention and Research Institute of Texas (CPRIT)2017–2018
Research History
- Research Associate• Planned and lead new projects aimed at construction of stable lentiviral packaging/producer cell lines for therapeutic vector production. • Supervised graduate students’ project on related topics and participate in the day to day running of the laboratory.2014 - 2015
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: